Check out our most popular compounded medications! Get Started
Ergotamine Tartrate 0.6 mg/Belladonna Extract 16 mg/Phenobarbital 40 mg Slow Release Capsules are formulated with Methocel E4M, a controlled-release polymer. This ensures a gradual release of the active ingredients, providing sustained therapeutic effects and reducing dosing frequency.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Ergotamine Tartrate 0.6 mg/Belladonna Extract 16 mg/Phenobarbital 40 mg Slow Release Capsules is a meticulously compounded medication, specifically designed to alleviate a range of conditions such as migraine headaches, tension headaches, and cluster headaches. This unique formulation is encapsulated using Methocel E4M, a controlled-release polymer. This innovative encapsulation technique ensures the gradual release of the active ingredients over an extended period, providing a sustained therapeutic effect.
This slow-release mechanism not only enhances the efficacy of the medication but also reduces the frequency of dosing, thereby improving patient compliance. This is particularly beneficial for medications that necessitate a controlled and prolonged release profile.
The combination of ergotamine tartrate, belladonna extract, and phenobarbital in this formulation synergistically works to mitigate the severity and duration of headaches. Additionally, this formulation may also prove beneficial in managing other conditions such as vertigo, nausea, and vomiting.
This medication is intended for oral administration. The capsule should be swallowed whole to ensure the controlled release of the active ingredients. It is imperative to adhere to the recommended dosage and not exceed more than two doses per day. Combining this medication with other drugs that contain ergotamine, belladonna, or phenobarbital should be avoided.
Special precautions should be taken by pregnant or nursing women, as well as individuals with certain medical conditions, as this formulation may not be suitable for them. It is always advisable to consult with a healthcare provider before starting any new medication.
If you have any questions or concerns about this formulation or its suitability for treating your specific condition, please do not hesitate to contact us. We are committed to providing personalized care and high-quality compounded medications to meet your unique healthcare needs.
Ergotamine Tartrate 0.6 mg/Belladonna Extract 16 mg/Phenobarbital 40 mg Slow Release Capsules are a compounded formulation that utilizes Methocel E4M, a controlled-release polymer. This innovative formulation ensures a gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects. This slow-release mechanism can lead to reduced dosing frequency and improved patient compliance, particularly beneficial for medications requiring a controlled and prolonged release profile.
It is important to note that these capsules may interact with other medications. This includes medications used to treat conditions such as migraine headaches, tension headaches, cluster headaches, and seizures. Therefore, it is crucial for patients to inform their healthcare provider of all medications they are currently taking, including over-the-counter medications, vitamins, and herbal supplements.
Interactions may occur with certain medications such as monoamine oxidase inhibitors (MAOIs), selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants, antifungal medications, antibiotics, anticoagulants, and anticonvulsants. Substances like alcohol, caffeine, and tobacco may also interact with these capsules.
Patients should be aware that these capsules may cause side effects such as drowsiness, dizziness, and blurred vision. It is advised not to drive or operate machinery until the effects of this medication are known. These capsules may also cause an increase in blood pressure, heart rate, and respiration. Patients should be monitored for these changes and should contact their healthcare provider if they experience any of these symptoms.
These capsules may also cause an increase in stomach acid production, leading to heartburn, nausea, and vomiting. An increase in liver enzymes, which can lead to liver damage, may also occur. Patients should contact their healthcare provider if they experience any of these symptoms.
Additionally, these capsules may cause an increase in blood sugar levels, potentially leading to hyperglycemia. An increase in uric acid levels, which can lead to gout, may also occur. Patients should contact their healthcare provider if they experience any of these symptoms.
If you have any questions about the interactions of Ergotamine Tartrate 0.6 mg/Belladonna Extract 16 mg/Phenobarbital 40 mg Slow Release Capsules, please consult with your healthcare provider.
Ergotamine Tartrate 0.6 mg/Belladonna Extract 16 mg/Phenobarbital 40 mg Slow Release Capsules is a specially compounded medication designed to manage and alleviate symptoms associated with various types of headaches, including migraines, tension headaches, and cluster headaches. The unique formulation works by constricting the blood vessels around the brain, reducing the volume of blood flow to the brain, and minimizing the release of certain natural substances that trigger pain.
The medication is encapsulated using Methocel E4M, a controlled-release polymer. This technology ensures the gradual release of the active ingredients over an extended period, providing sustained therapeutic effects. The slow-release mechanism enhances the efficacy of the medication, reduces the frequency of dosing, and improves patient compliance, particularly for medications that require a controlled and prolonged release profile.
The medication is administered orally, typically once a day, as per the doctor's prescription. It is crucial to adhere to the prescribed dosage and not to exceed or reduce the recommended dose. The medication should not be taken more frequently than prescribed by the doctor.
Some potential side effects of this medication include drowsiness, dizziness, or blurred vision. It is advised not to drive or operate heavy machinery until you are aware of how this medication affects you. Consumption of alcoholic beverages should be avoided while on this medication.
This medication may also cause constipation. To prevent this, maintain a diet rich in fiber, drink ample water, and engage in regular exercise. If constipation occurs, consult your doctor. Dry mouth is another potential side effect. To alleviate this, you can suck on sugarless hard candy or ice chips, chew sugarless gum, drink water, or use a saliva substitute.
If you have any queries or concerns regarding this medication, do not hesitate to contact your healthcare provider. They are there to assist you with your healthcare needs.
This compounded formulation combines Ergotamine Tartrate 0.6 mg, Belladonna Extract 16 mg, and Phenobarbital 40 mg in slow-release capsules, designed to provide sustained therapeutic effects over an extended period of time. The capsules are formulated with Methocel E4M, a controlled-release polymer, which allows for a gradual release of the encapsulated medication. This results in reduced dosing frequency and improved patient compliance, making it particularly beneficial for medications requiring a controlled and prolonged release profile.
The formulation is primarily used for the treatment and prevention of various types of headaches, including chronic daily headaches, chronic migraines, tension headaches, post-traumatic headaches, and headaches associated with other medical conditions. Additionally, it can be used to manage other conditions such as vertigo, dizziness, and nausea.
Despite its wide range of applications, this formulation is not recommended for use in children or pregnant women. Patients using this medication should be closely monitored for any adverse effects, including but not limited to nausea, vomiting, or dizziness. In the event of any such symptoms, it is advised to contact a healthcare provider immediately.
Always consult with your healthcare provider for any questions or concerns regarding the use of this formulation. It is also crucial to remember that the effectiveness of this formulation can vary from person to person, and it may not be suitable for everyone. Therefore, it is essential to discuss your medical history and current medications with your healthcare provider before starting this medication.
Furthermore, while this formulation is designed to provide sustained therapeutic effects, it is not a cure for the underlying conditions. It is intended to manage symptoms and improve the quality of life for patients. Therefore, it is essential to continue other recommended treatments and lifestyle modifications alongside this medication.
Lastly, it is important to take this medication exactly as prescribed by your healthcare provider. Do not alter the dosage or stop taking the medication without consulting your healthcare provider. Doing so could lead to adverse effects or a decrease in the medication's effectiveness.
Methocel E4M is a type of controlled-release polymer. It is designed to release the encapsulated medication or active ingredient gradually over an extended period of time. This offers sustained therapeutic effects, reduces dosing frequency, and improves patient compliance for medications requiring a controlled and prolonged release profile.
The active ingredients in these capsules are Ergotamine Tartrate 0.6 mg, Belladonna Extract 16 mg, and Phenobarbital 40 mg.
Slow release capsules provide a steady release of medication over an extended period of time. This can help to maintain a consistent level of medication in the body, potentially improving the effectiveness of the treatment and reducing the frequency of dosing.
As these capsules are designed to release medication over an extended period, they may not need to be taken as frequently as other forms of medication. However, the exact dosing schedule should be determined by your healthcare provider based on your specific needs and condition.
As with any medication, these capsules can have potential side effects. These can vary depending on the individual and the specific medication. It's important to discuss potential side effects with your healthcare provider before starting any new medication.
It's important to discuss all medications you are currently taking with your healthcare provider before starting any new medication. They can provide guidance on potential interactions and determine the best course of treatment for your specific needs.
If you miss a dose, take it as soon as you remember. If it is close to the time for your next dose, skip the missed dose and go back to your normal time. Do not take 2 doses at the same time or extra doses. Always consult your healthcare provider if you are unsure.
These capsules are designed to release medication slowly over time. Crushing or breaking the capsule could result in too much medication being released at once. Always take the capsule whole, unless directed otherwise by your healthcare provider.
Before taking any medication, it's important to discuss with your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding. They can provide guidance on the safest course of treatment for you and your baby.
Store these capsules at room temperature, away from heat and direct light. Do not freeze. Keep out of the reach of children. Do not keep outdated medicine or medicine no longer needed. Always consult your healthcare provider or pharmacist if you have questions about the storage of your medication.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
